Boon Industries, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BNOW research report →
Price Chart
About the company
Boon Industries, Inc. is a bioscience firm that engineers chemical products catering to a diverse range of sectors, including agriculture, food and beverages, hospitality, and healthcare, serving both domestic and global markets. Its flagship offering is DiOx+, an activated chlorine dioxide formula designed as a potent disinfectant and sterilizer.
- CEO
- William J. Reed
- Employees
- 2
- HQ
- Grass Valley, CA, US
Get TickerSpark's AI analysis on BNOW
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $73.42M
- P/E
- -0.02
- PEG
- -0.00
- P/S
- 2132.19
- P/B
- -0.00
- EV/EBITDA
- -22.16
- Div Yield
- 0.00%
- Gross Margin
- 63.66%
- Op Margin
- -6910.85%
- Net Margin
- -15535.51%
- ROE
- 7.70%
- ROIC
- 3.44%
Latest fiscal year · YoY change
- Revenue
- $34.43K-60.1%
- Gross Profit
- $21.92K-60.4%
- Op Income
- $-2,379,683
- Net Income
- $-5,349,499-7.0%
- EPS
- $-1.13+93.1%
- OCF Growth
- +54.2%
- FCF Growth
- +52.0%
- 52W High
- $1.00
- 52W Low
- $0.02
- 50D MA
- $0.09
- 200D MA
- $0.13
- Beta
- 2.44
- RSI (14)
- 39
- Avg Volume
- 28.74K
No earnings-call transcripts are available for BNOW yet.
- Free Float
- 0.0%
- Shares Outstanding
- 3.50B
- Float Shares
- 0
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 29, 22 | Goyette Paul Quentin | other | 10,000 |
| Sep 29, 22 | Goyette Paul Quentin | other | 0 |
| Sep 29, 22 | Goyette Paul Quentin | other | 0 |
| Sep 29, 22 | Reed William Joseph | other | 500,000 |
| Sep 7, 22 | Reed William Joseph | other | 15,000 |
| Sep 7, 22 | Reed William Joseph | other | 0 |
| Feb 14, 22 | Watson Eric Jason | other | 0 |
| Feb 14, 22 | LOEWEN JOHANN | other | 0 |
| Feb 14, 22 | Gonzalez Justin Michael | other | 0 |
| Feb 14, 22 | Gonzalez Justin Michael | other | 250,000,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BNOW coverage
Recent articles, reports, and earnings notes.
No research on BNOW yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BNOW report →Boon Industries Releases Investor Presentation
globenewswire.com · Sep 29
Boon Files Form 10 with Securities and Exchange Commission
globenewswire.com · Aug 29
Boon Positions DiOx+ as Catalyst for Revenue Growth in Crop Protection Market
globenewswire.com · Jun 14
Boon Industries Retains Integrity Media for Investor Relations and Corporate Communication
globenewswire.com · Jun 2
BOON Industries Continues to Expand Distribution of DiOx+ Into New Verticals
globenewswire.com · Mar 10
The Pandemic is a Long-Term Factor (NASDAQ: QDEL) (NYSEAMERICAN: APT) (OTC US: BNOW) (NYSE: ABT)
otcprwire.com · Mar 4
BOON Completes Phase-I of EPA Testing of DIOX+ $25M Revenue on Horizon
globenewswire.com · Mar 1
BOON to Announce Major Contract Start Date for DIOX+ $52M Revenue Stream
globenewswire.com · Feb 3
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.